Anticardiolipin and Antibeta2glycoproteinI Antibodies in Patients with Hepatitis B and C Infections

Authors

  • Akbar Rajaee Department of Internal Medicine, Rheumatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Elham Aflaki Department of Internal Medicine, Rheumatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Mohammad Ali Nazarinia Department of Internal Medicine, Rheumatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Zahra Habibagahi Department of Internal Medicine, Rheumatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract:

Background: The clinical significance of antiphospholipid antibodies in patients with chronic hepatitis C virus (HCV) and some other viral infections is controversial. Objective: To study the prevalence of anticardiolipin antibody (ACLA) and antibeta2glycoproteinI antibody (antibeta2GPI antibody) in HCV and hepatitis B virus (HBV) infected patients and its association with liver clinical parameters. Methods: Serum levels of ACLA, antibeta2GPI antibody as well as platelet count, ALT (alanine transaminase), PT (prothrombine time), disease duration and liver histologic findings of 38 patients with HBV and 15 patients with HCV infections were compared with those of 58 healthy controls. Results: Serum titres of ACLA in HCV and HBV patients (13.4 ±7.1 GPL units/ml), and in each of the HCV (15.18±9.91 GPL units/ml) and HBV (12.7 ± 5.7 GPL units/ml) patients were significantly higher than that of the control group (3.4±2.3GPL units/ml). However, there was no significant difference in serum levels of antibeta2GPI antibody from patients with HCV and HBV (3.3 ± 1.3 GPL units/ml) or HCV alone (2.79 ± 1.01 GPL units/ml) or HBV alone (3.4±1.3GPL units/ml) and that of the control group (3.3±1.1GPL units/ml). Conclusion: The findings suggest that the presence of ACLA has no pathologic significance in patients with HBV and HCV infections.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

anticardiolipin and antibeta2glycoproteini antibodies in patients with hepatitis b and c infections

background: the clinical significance of antiphospholipid antibodies in patients with chronic hepatitis c virus (hcv) and some other viral infections is controversial. objective: to study the prevalence of anticardiolipin antibody (acla) and antibeta2glycoproteini antibody (antibeta2gpi antibody) in hcv and hepatitis b virus (hbv) infected patients and its association with liver clinical parame...

full text

CHARACTERISTICS AND PREVALENCE OF OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH HEPATITIS C IN IRAN

 ABSTRACT Background: Hepatitis B virus (HBV) infection in patients who lack detectable hepatitis B surface antigen (HBsAg) is called occult hepatitis B infection. Such infections have been frequently identified in patients with chronic hepatitis Cliver disease, but their prevalence is not known. Methods: 207 patients with chronic hepatitis C who were HCV -RNA and antiHCV positive were stu...

full text

Prevalence of Hepatitis B virus, Hepatitis C virus and human immunodeficiency virus infections among patients candidate for orthopedic trauma surgeries

Background: Infectious diseases are major public health problems, among which blood-borne ones are the most important infections. Patients who undergo orthopedic surgery are at higher risk of transmitting infectious diseases from and to others, due to repeated blood examinations and injection, drains secretion and receiving blood products. Accordingly, in this study we determined prevalence of ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 4  issue 3

pages  161- 166

publication date 2007-12-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023